Open AccessEfficacy of switching to rilpivirine/emtricitabine/tenofovir DF from boosted PI in HIV-1 virologically suppressed patients with or without the K103N
Author(s) -
F Pallela,
Pablo Tebas,
Martin Fisher,
Brian Gazzard,
P. Ruane,
Jan van Lunzen,
David Shamblaw,
Jason Flamm,
Ramin Ebrahimi,
Danielle Porter,
K White,
Shampa De-Oertel,
Todd Fralich,
Romina Quercia
Publication year - 2013
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.7448/ias.16.2.18681
Subject(s) - rilpivirine , emtricitabine , medicine , tenofovir , human immunodeficiency virus (hiv) , virology , pharmacology , antiretroviral therapy , viral load
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom